{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T11:43:41Z","timestamp":1793187821825,"version":"4.5.0"},"reference-count":112,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T00:00:00Z","timestamp":1685491200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Health Serv."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Patients with genetic cancer susceptibility are presented with complex management options involving difficult decisions, for example about genetic testing, treatment, screening and risk-reducing surgery\/medications. This review sought to explore the experience of patients using decision support resources in this context, and the impact on decision-making outcomes.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Systematic review of quantitative, qualitative and mixed-methods studies involving adults with or without cancer who used a decision support resource pre- or post-genetic test for any cancer susceptibility. To gather a broad view of existing resources and gaps for development, digital or paper-based patient resources were included and not limited to decision aids. Narrative synthesis was used to summarise patient impact and experience.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Thirty-six publications describing 27 resources were included. Heterogeneity of resources and outcome measurements highlighted the multiple modes of resource delivery and personal tailoring acceptable to and valued by patients. Impact on cognitive, emotional, and behavioural outcomes was mixed, but mainly positive. Findings suggested clear potential for quality patient-facing resources to be acceptable and useful.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Decision support resources about genetic cancer susceptibility are likely useful to support decision-making, but should be co-designed with patients according to evidence-based frameworks. More research is needed to study impact and outcomes, particularly in terms of longer term follow-up to identify whether patients follow through on decisions and whether any increased distress is transient. Innovative, streamlined resources are needed to scale up delivery of genetic cancer susceptibility testing for patients with cancer in mainstream oncology clinics. Tailored patient-facing decision aids should also be made available to patients identified as carriers of a pathogenic gene variant that increases future cancer risks, to complement traditional genetic counselling.<\/jats:p><\/jats:sec><jats:sec><jats:title>Systematic Review Registration<\/jats:title><jats:p><jats:ext-link>https:\/\/www.crd.york.ac.uk\/prospero\/display_record.php?ID=CRD42020220460<\/jats:ext-link>, identifier: CRD42020220460.<\/jats:p><\/jats:sec>","DOI":"10.3389\/frhs.2023.1092816","type":"journal-article","created":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T09:27:41Z","timestamp":1685525261000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":14,"title":["Patient decision support resources inform decisions about cancer susceptibility genetic testing and risk management: a systematic review of patient impact and experience"],"prefix":"10.3389","volume":"3","author":[{"given":"Kelly","family":"Kohut","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"Morton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lesley","family":"Turner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Shepherd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicky","family":"Fenerty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lois","family":"Woods","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chloe","family":"Grimmett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana M.","family":"Eccles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Foster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,5,31]]},"reference":[{"key":"B1","year":""},{"key":"B2","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1136\/gut.2009.179804","article-title":"Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002)","volume":"59","author":"Cairns","year":"2010","journal-title":"Gut"},{"key":"B3","year":""},{"key":"B4","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s10897-005-9014-3","article-title":"A new definition of genetic counseling: national society of genetic Counselors\u2019 task force report","volume":"15","author":"Resta","year":"2006","journal-title":"J Genet Couns"},{"key":"B5","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1007\/s10897-016-0023-1","article-title":"Theories for psychotherapeutic genetic counseling: fuzzy trace theory and cognitive behavior theory","volume":"26","author":"Biesecker","year":"2017","journal-title":"J Genet Couns"},{"key":"B6","doi-asserted-by":"publisher","first-page":"3759","DOI":"10.1158\/1078-0432.CCR-18-0968","article-title":"PARP Inhibitors: extending benefit beyond BRCA-mutant cancers","volume":"25","author":"Pili\u00e9","year":"2019","journal-title":"Clin Cancer Res"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1093\/annonc\/mdz116","article-title":"ESMO Recommendations on microsatellite instability testing for immunotherapy in cancer, and its relationship with PD-1\/PD-L1 expression and tumour mutational burden: a systematic review-based approach","volume":"30","author":"Luchini","year":"2019","journal-title":"Ann Oncol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s10549-017-4531-y","article-title":"Clinical implications of germline mutations in breast cancer: tP53","volume":"167","author":"Schon","year":"2018","journal-title":"Breast Cancer Res Treat"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1016\/j.annonc.2020.07.014","article-title":"Recommendations for the use of next-generation sequencing (NGS) for patients with metastatic cancers: a report from the ESMO precision medicine working group","volume":"31","author":"Mosele","year":"2020","journal-title":"Ann Oncol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1093\/annonc\/mdz136","article-title":"Germline-focussed analysis of tumour-only sequencing: recommendations from the ESMO precision medicine working group","volume":"30","author":"Mandelker","year":"2019","journal-title":"Ann Oncol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1038\/s41588-018-0202-0","article-title":"Cancer genetics, precision prevention and a call to action","volume":"50","author":"Turnbull","year":"2018","journal-title":"Nat Genet"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1038\/s41591-020-0982-5","article-title":"Population genetic screening efficiently identifies carriers of autosomal dominant diseases","volume":"26","author":"Grzymski","year":"2020","journal-title":"Nat Med"},{"key":"B13","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1111\/1471-0528.15905","article-title":"Randomised trial of population-based BRCA testing in ashkenazi Jews: long-term outcomes","volume":"127","author":"Manchanda","year":"2020","journal-title":"Bjog"},{"key":"B14","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/s10897-017-0067-x","article-title":"A rapid systematic review of outcomes studies in genetic counseling","volume":"26","author":"Madlensky","year":"2017","journal-title":"J Genet Couns"},{"key":"B15","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.pec.2019.08.010","article-title":"Effect of interventions including provision of personalised cancer risk information on accuracy of risk perception and psychological responses: a systematic review and meta-analysis","volume":"103","author":"Bayne","year":"2020","journal-title":"Patient Educ Couns"},{"key":"B16","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.ypmed.2019.02.027","article-title":"Genetic counseling, genetic testing, and risk perceptions for breast and colorectal cancer: results from the 2015 national health interview survey","volume":"123","author":"Turbitt","year":"2019","journal-title":"Prev Med"},{"key":"B17","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1126\/science.7455683","article-title":"The framing of decisions and the psychology of choice","volume":"211","author":"Tversky","year":"1981","journal-title":"Science"},{"key":"B18","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1177\/0272989X08327395","article-title":"Anchoring-and-Adjustment bias in communication of disease risk","volume":"29","author":"Senay","year":"2008","journal-title":"Med Decis Making"},{"key":"B19","year":""},{"key":"B20","year":""},{"key":"B21","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001431.pub2","article-title":"Decision aids for people facing health treatment or screening decisions","volume":"3","author":"O\u2019Connor","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"B22","doi-asserted-by":"publisher","first-page":"e4705","DOI":"10.1371\/journal.pone.0004705","article-title":"Assessing the quality of decision support technologies using the international patient decision aid standards instrument (IPDASi)","volume":"4","author":"Elwyn","year":"2009","journal-title":"PLoS One"},{"key":"B23","article-title":"Decision aids for people facing health treatment or screening decisions","volume":"4","author":"Stacey","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"B24","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1177\/0272989X07307319","article-title":"Do patient decision aids meet effectiveness criteria of the international patient decision aid standards collaboration? A systematic review and meta-analysis","volume":"27","author":"O\u2019Connor","year":"2007","journal-title":"Med Decis Making"},{"key":"B25","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.pec.2007.12.004","article-title":"Where is the theory? Evaluating the theoretical frameworks described in decision support technologies","volume":"71","author":"Durand","year":"2008","journal-title":"Patient Educ Couns"},{"key":"B26","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1038\/gim.2012.40","article-title":"Telegenetics: a systematic review of telemedicine in genetics services","volume":"14","author":"Hilgart","year":"2012","journal-title":"Genet Med"},{"key":"B27","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1097\/GIM.0b013e3181c60955","article-title":"Hereditary breast and ovarian cancer: referral source for genetic assessment and communication regarding assessment with nongenetic clinicians in the community setting","volume":"12","author":"Morgan","year":"2010","journal-title":"Genet Med"},{"key":"B28","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s10689-013-9686-z","article-title":"More breast cancer patients prefer BRCA-mutation testing without prior face-to-face genetic counseling","volume":"13","author":"Sie","year":"2014","journal-title":"Fam Cancer"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3390\/jpm8030025","article-title":"Early outcome data assessing utility of a post-test genomic counseling framework for the scalable delivery of precision health","volume":"8","author":"Sturm","year":"2018","journal-title":"J Pers Med"},{"key":"B30","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/j.pec.2017.11.016","article-title":"Systematic review of the empirical investigation of resources to support decision-making regarding BRCA1 and BRCA2 genetic testing in women with breast cancer","volume":"101","author":"Grimmett","year":"2018","journal-title":"Patient Educ Couns"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1186\/s12911-019-0872-2","article-title":"Effectiveness of decision aids for female BRCA1 and BRCA2 mutation carriers: a systematic review","volume":"19","author":"Krassuski","year":"2019","journal-title":"BMC Med Inform Decis Mak"},{"key":"B32","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1186\/s12911-021-01528-4","article-title":"Development of decision aids for female BRCA1 and BRCA2 mutation carriers in Germany to support preference-sensitive decision-making","volume":"21","author":"Kautz-Freimuth","year":"2021","journal-title":"BMC Med Inform Decis Mak"},{"key":"B33","year":"2009"},{"key":"B34","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"Br Med J"},{"key":"B35","author":"Rayyan","year":""},{"key":"B36","doi-asserted-by":"publisher","first-page":"g1687","DOI":"10.1136\/bmj.g1687","article-title":"Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide","volume":"348","author":"Hoffmann","year":"2014","journal-title":"BMJ: British Medical Journal"},{"key":"B37","year":"2012"},{"key":"B38","author":"Hong","year":""},{"key":"B39","doi-asserted-by":"publisher","first-page":"l6890","DOI":"10.1136\/bmj.l6890","article-title":"Synthesis without meta-analysis (SWiM) in systematic reviews: reporting guideline","volume":"368","author":"Campbell","year":"2020","journal-title":"Br Med J"},{"key":"B40","author":"Popay","year":""},{"key":"B41","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1258\/1355819054308576","article-title":"Systematically reviewing qualitative and quantitative evidence to inform management and policy-making in the health field","volume":"10","author":"Mays","year":"2005","journal-title":"J Health Serv Res Policy"},{"key":"B42","doi-asserted-by":"publisher","first-page":"989","DOI":"10.7326\/0003-4819-127-11-199712010-00008","article-title":"Integrating heterogeneous pieces of evidence in systematic reviews","volume":"127","author":"Mulrow","year":"1997","journal-title":"Ann Intern Med"},{"key":"B43","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1007\/s13187-011-0227-x","article-title":"Use and evaluation of an individually tailored website for counselees prior to breast cancer genetic counseling","volume":"26","author":"Albada","year":"2011","journal-title":"J Cancer Educ"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0200559","article-title":"Improving comprehension of genetic counseling for hereditary breast and ovarian cancer clients with a visual tool","volume":"13","author":"Tea","year":"2018","journal-title":"Plos One"},{"key":"B45","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s13187-019-1470-9","article-title":"Development and testing of a decision aid for unaffected women with a BRCA1 or BRCA2 mutation","volume":"35","author":"Jabaley","year":"2020","journal-title":"J Cancer Educ"},{"key":"B46","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s10689-012-9577-8","article-title":"Feasibility evaluation of an online tool to guide decisions for BRCA1\/2 mutation carriers","volume":"12","author":"Schackmann","year":"2013","journal-title":"Fam Cancer"},{"key":"B47","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1111\/hex.12661","article-title":"A patient decision aid for risk-reducing surgery in premenopausal BRCA1\/2 mutation carriers: development process and pilot testing","volume":"21","author":"Harmsen","year":"2018","journal-title":"Health Expect"},{"key":"B48","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1136\/jmedgenet-2020-107294","article-title":"Using chatbots to screen for heritable cancer syndromes in patients undergoing routine colonoscopy","volume":"58","author":"Heald","year":"2020","journal-title":"J Med Genet"},{"key":"B49","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1007\/s13187-019-01599-y","article-title":"The genetic education for men (GEM) trial: development of web-based education for untested men in BRCA1\/2-positive families","volume":"36","author":"Peshkin","year":"2021","journal-title":"J Cancer Educ"},{"key":"B50","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1007\/s13187-014-0643-9","article-title":"From observation to intervention: development of a psychoeducational intervention to increase uptake of BRCA genetic counseling among high-risk breast cancer survivors","volume":"29","author":"Vadaparampil","year":"2014","journal-title":"J Cancer Educ"},{"key":"B51","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1136\/jmedgenet-2015-103740","article-title":"Cluster-randomised non-inferiority trial comparing DVD-assisted and traditional genetic counselling in systematic population testing for BRCA1\/2 mutations","volume":"53","author":"Manchanda","year":"2016","journal-title":"J Med Genet"},{"key":"B52","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.breast.2017.10.001","article-title":"Facilitating decision-making in women undergoing genetic testing for hereditary breast cancer: bRECONDA randomized controlled trial results","volume":"36","author":"Sherman","year":"2017","journal-title":"Breast"},{"key":"B53","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.pec.2014.10.005","article-title":"Follow-up effects of a tailored pre-counseling website with question prompt in breast cancer genetic counseling","volume":"98","author":"Albada","year":"2015","journal-title":"Patient Educ Couns"},{"key":"B54","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.ygyno.2018.12.027","article-title":"Modified panel-based genetic counseling for ovarian cancer susceptibility: a randomized non-inferiority study","volume":"153","author":"McCuaig","year":"2019","journal-title":"Gynecol Oncol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/gim.2016.108","article-title":"Effect of decision aid for breast cancer prevention on decisional conflict in women with a BRCA1 or BRCA2 mutation: a multisite, randomized, controlled trial","volume":"19","author":"Metcalfe","year":"2017","journal-title":"Genet Med"},{"key":"B56","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/gim.2011.42","article-title":"A pre-visit website with question prompt sheet for counselees facilitates communication in the first consultation for breast cancer genetic counseling: findings from a randomized controlled trial","volume":"14","author":"Albada","year":"2012","journal-title":"Genet Med"},{"key":"B57","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/s10549-018-5000-y","article-title":"High patient satisfaction with a simplified BRCA1\/2 testing procedure: long-term results of a prospective study","volume":"173","author":"Nilsson","year":"2019","journal-title":"Breast Cancer Res Treat"},{"key":"B58","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1007\/s10897-015-9899-4","article-title":"High satisfaction and low distress in breast cancer patients one year after BRCA-mutation testing without prior face-to-face genetic counseling","volume":"25","author":"Sie","year":"2016","journal-title":"J Genet Couns"},{"key":"B59","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1177\/0272989X10381283","article-title":"Longitudinal changes in patient distress following interactive decision aid use among BRCA1\/2 carriers: a randomized trial","volume":"31","author":"Hooker","year":"2011","journal-title":"Med Decis Making"},{"key":"B60","doi-asserted-by":"publisher","first-page":"E101","DOI":"10.1188\/12.ONF.E101-E111","article-title":"Getting to the point: what women newly diagnosed with breast cancer want to know about treatment-focused genetic testing","volume":"39","author":"Meiser","year":"2012","journal-title":"Oncol Nurs Forum"},{"key":"B61","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1080\/10410236.2019.1598612","article-title":"A framework for pilot testing health risk video narratives","volume":"35","author":"Scherr","year":"2020","journal-title":"Health Commun"},{"key":"B62","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s12687-019-00450-7","article-title":"Online BRCA1\/2 screening in the Australian Jewish community: a qualitative study","volume":"11","author":"Yuen","year":"2020","journal-title":"J Community Genet"},{"key":"B63","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1007\/s10897-011-9350-4","article-title":"Development and evaluation of a decision aid for BRCA carriers with breast cancer","volume":"20","author":"Culver","year":"2011","journal-title":"J Genet Couns"},{"key":"B64","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s00520-018-4307-x","article-title":"Development of breast cancer choices: a decision support tool for young women with breast cancer deciding whether to have genetic testing for BRCA1\/2 mutations","volume":"27","author":"Grimmett","year":"2019","journal-title":"Support Care Cancer"},{"key":"B65","doi-asserted-by":"publisher","first-page":"4000","DOI":"10.1002\/cncr.31731","article-title":"Knowledge regarding and patterns of genetic testing in patients newly diagnosed with breast cancer participating in the iCanDecide trial","volume":"124","author":"Gornick","year":"2018","journal-title":"Cancer"},{"key":"B66","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1002\/pon.5059","article-title":"A randomized controlled intervention to promote readiness to genetic counseling for breast cancer survivors","volume":"28","author":"Kasting","year":"2019","journal-title":"Psychooncology"},{"key":"B67","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/gim.2016.130","article-title":"Streamlined genetic education is effective in preparing women newly diagnosed with breast cancer for decision making about treatment-focused genetic testing: a randomized controlled noninferiority trial","volume":"19","author":"Quinn","year":"2017","journal-title":"Genet Med"},{"key":"B68","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.ygyno.2016.07.094","article-title":"Video-assisted genetic counseling in patients with ovarian, fallopian and peritoneal carcinoma","volume":"143","author":"Watson","year":"2016","journal-title":"Gynecol Oncol"},{"key":"B69","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1080\/0284186X.2018.1502466","article-title":"Cancer-related distress in unselected women with newly diagnosed breast or ovarian cancer undergoing BRCA1\/2 testing without pretest genetic counseling","volume":"58","author":"H\u00f8berg-Vetti","year":"2019","journal-title":"Acta Oncol"},{"key":"B70","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1111\/codi.12880","article-title":"Improving recognition and referral of patients with an increased familial risk of colorectal cancer: results from a randomized controlled trial","volume":"17","author":"Dekker","year":"2015","journal-title":"Colorectal Dis"},{"key":"B71","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1158\/1055-9965.EPI-10-0685","article-title":"Effects of a decision support intervention on decisional conflict associated with microsatellite instability testing","volume":"20","author":"Hall","year":"2011","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"B72","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1177\/0272989X18819493","article-title":"Visual representations of risk enhance long-term retention of risk information: a randomized trial","volume":"39","author":"Arrick","year":"2019","journal-title":"Med Decis Making"},{"key":"B73","doi-asserted-by":"publisher","first-page":"841","DOI":"10.6004\/jnccn.2020.7546","article-title":"A web-based tool to automate portions of pretest genetic counseling for inherited cancer","volume":"18","author":"Cragun","year":"2020","journal-title":"J Natl Compr Canc Netw"},{"key":"B74","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s10689-011-9479-1","article-title":"A pre-visit tailored website enhances counselees\u2019 realistic expectations and knowledge and fulfils information needs for breast cancer genetic counselling","volume":"11","author":"Albada","year":"2012","journal-title":"Fam Cancer"},{"key":"B75","first-page":"123","article-title":"The elaboration likelihood model of persuasion","volume-title":"Advances in experimental social psychology","author":"Petty","year":"1986"},{"key":"B76","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1177\/0272989X08327066","article-title":"A theory of medical decision making and health: fuzzy trace theory","volume":"28","author":"Reyna","year":"2008","journal-title":"Med Decis Making"},{"key":"B77","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/109019818401100101","article-title":"The health belief model: a decade later","volume":"11","author":"Janz","year":"1984","journal-title":"Health Educ Q"},{"key":"B78","doi-asserted-by":"publisher","first-page":"38","DOI":"10.4278\/0890-1171-12.1.38","article-title":"The transtheoretical model of health behavior change","volume":"12","author":"Prochaska","year":"1997","journal-title":"Am J Health Promot"},{"key":"B79","year":""},{"key":"B80","doi-asserted-by":"crossref","DOI":"10.1017\/CBO9781139174084","volume-title":"Decisions with multiple objectives: Preferences and value trade-offs","author":"Keeney","year":"1993"},{"key":"B81","doi-asserted-by":"crossref","DOI":"10.4135\/9781412985123","volume-title":"Multiattribute evaluation","author":"Edwards","year":"1982"},{"key":"B82","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/S0738-3991(02)00089-7","article-title":"The multi-dimensional measure of informed choice: a validation study","volume":"48","author":"Michie","year":"2002","journal-title":"Patient Educ Couns"},{"key":"B83","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/S0738-3991(03)00044-2","article-title":"Informed choice: understanding knowledge in the context of screening uptake","volume":"50","author":"Michie","year":"2003","journal-title":"Patient Educ Couns"},{"key":"B84","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1038\/ejhg.2015.196","article-title":"BRCA1\/2 Testing in newly diagnosed breast and ovarian cancer patients without prior genetic counselling: the DNA-BONus study","volume":"24","author":"H\u00f8berg-Vetti","year":"2016","journal-title":"Eur J Hum Genet"},{"key":"B85","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s10549-017-4584-y","article-title":"BRCAsearch: written pre-test information and BRCA1\/2 germline mutation testing in unselected patients with newly diagnosed breast cancer","volume":"168","author":"Nilsson","year":"2018","journal-title":"Breast Cancer Res Treat"},{"key":"B86","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/s41436-018-0021-9","article-title":"Written pretest information and germline BRCA1\/2 pathogenic variant testing in unselected breast cancer patients: predictors of testing uptake","volume":"21","author":"Nilsson","year":"2019","journal-title":"Genet Med"},{"key":"B87","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1177\/0272989X9501500105","article-title":"Validation of a decisional conflict scale","volume":"15","author":"O\u2019Connor","year":"1995","journal-title":"Med Decis Making"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.3389\/fdgth.2022.1039701","article-title":"Person-based co-design of a decision aid template for people with a genetic predisposition to cancer","volume":"4","author":"Morton","year":"2022","journal-title":"Front in Dig Health"},{"key":"B89","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1177\/0272989X20924645","article-title":"20th Anniversary update of the Ottawa decision support framework: part 2 subanalysis of a systematic review of patient decision aids","volume":"40","author":"Hoefel","year":"2020","journal-title":"Med Decis Making"},{"key":"B90","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1177\/0272989X20911870","article-title":"20th Anniversary Ottawa decision support framework: part 3 overview of systematic reviews and updated framework","volume":"40","author":"Stacey","year":"2020","journal-title":"Med Decis Making"},{"key":"B91","year":""},{"key":"B92","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1001\/jamainternmed.2017.8049","article-title":"Web platform vs in-person genetic counselor for return of carrier results from exome sequencing A randomized clinical trial","volume":"178","author":"Biesecker","year":"2018","journal-title":"JAMA Intern Med"},{"key":"B93","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1158\/0008-5472.CAN-19-0728","article-title":"Penetrance of different cancer types in families with li-fraumeni syndrome: a validation study using multicenter cohorts","volume":"80","author":"Shin","year":"2020","journal-title":"Cancer Res"},{"key":"B94","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/nrclinonc.2016.90","article-title":"Counselling framework for moderate-penetrance cancer-susceptibility mutations","volume":"13","author":"Tung","year":"2016","journal-title":"Nat Rev Clin Oncol"},{"key":"B95","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1002\/path.5229","article-title":"Genetic predisposition to colorectal cancer: syndromes, genes, classification of genetic variants and implications for precision medicine","volume":"247","author":"Valle","year":"2019","journal-title":"J Pathol"},{"key":"B96","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s13058-019-1193-1","article-title":"Li-Fraumeni syndrome: not a straightforward diagnosis anymore-the interpretation of pathogenic variants of low allele frequency and the differences between germline PVs, mosaicism, and clonal hematopoiesis","volume":"21","author":"Batalini","year":"2019","journal-title":"Breast Cancer Res"},{"key":"B97","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/s41436-019-0596-9","article-title":"Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the prospective lynch syndrome database","volume":"22","author":"Dominguez-Valentin","year":"2020","journal-title":"Genet Med"},{"key":"B98","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1001\/jama.2017.7112","article-title":"Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers","volume":"317","author":"Kuchenbaecker","year":"2017","journal-title":"Jama"},{"key":"B99","doi-asserted-by":"publisher","first-page":"3673","DOI":"10.1002\/cncr.30248","article-title":"Risks of first and subsequent cancers among TP53 mutation carriers in the national cancer institute li-fraumeni syndrome cohort","volume":"122","author":"Mai","year":"2016","journal-title":"Cancer"},{"key":"B100","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/1467-9566.13010","article-title":"Managing ethical uncertainty: implicit normativity and the sociology of ethics","volume":"42","author":"Cribb","year":"2020","journal-title":"Sociol Health Illn"},{"key":"B101","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1177\/0272989X10393976","article-title":"Varieties of uncertainty in health care: a conceptual taxonomy","volume":"31","author":"Han","year":"2011","journal-title":"Med Decis Making"},{"key":"B102","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1038\/gim.2016.212","article-title":"A taxonomy of medical uncertainties in clinical genome sequencing","volume":"19","author":"Han","year":"2017","journal-title":"Genet Med"},{"key":"B103","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s12920-016-0219-0","article-title":"Known unknowns: building an ethics of uncertainty into genomic medicine","volume":"9","author":"Newson","year":"2016","journal-title":"BMC Med Genomics"},{"key":"B104","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1177\/0190272516658770","article-title":"Negotiating the diagnostic uncertainty of genomic test\u00a0results","volume":"79","author":"Stivers","year":"2016","journal-title":"Soc Psychol Q"},{"key":"B105","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1111\/j.1460-2466.2001.tb02892.x","article-title":"Communication and uncertainty management","volume":"51","author":"Brashers","year":"2001","journal-title":"Journal of Communication"},{"key":"B106","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s12687-018-0371-7","article-title":"Ethics in genetic counselling","volume":"10","author":"Clarke","year":"2019","journal-title":"J Community Genet"},{"key":"B107","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/23294515.2020.1823907","article-title":"Participant reactions to a literacy-focused, web-based informed consent approach for a genomic implementation study","volume":"12","author":"Kraft","year":"2021","journal-title":"AJOB Empir Bioeth"},{"key":"B108","first-page":"24","article-title":"NHS Long term plan","author":"England","year":"2019"},{"key":"B109","year":"2019"},{"key":"B110","doi-asserted-by":"publisher","first-page":"e30","DOI":"10.2196\/jmir.4055","article-title":"The person-based approach to intervention development: application to digital health-related behavior change interventions","volume":"17","author":"Yardley","year":"2015","journal-title":"J Med Internet Res"},{"key":"B111","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1177\/135638902401462448","article-title":"Evidence-based policy: the promise of `realist synthesis\u2019","volume":"8","author":"Pawson","year":"2002","journal-title":"Evaluation"},{"key":"B112","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1258\/1355819054308530","article-title":"Realist review\u2014a new method of systematic review designed for complex policy interventions","volume":"10","author":"Pawson","year":"2005","journal-title":"J Health Serv Res Policy"}],"container-title":["Frontiers in Health Services"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/frhs.2023.1092816\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,14]],"date-time":"2023-12-14T13:12:54Z","timestamp":1702559574000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/frhs.2023.1092816\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,31]]},"references-count":112,"alternative-id":["10.3389\/frhs.2023.1092816"],"URL":"https:\/\/doi.org\/10.3389\/frhs.2023.1092816","relation":{},"ISSN":["2813-0146"],"issn-type":[{"value":"2813-0146","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,31]]},"article-number":"1092816"}}